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Introduction
Leptin is a 16-kDa adipocyte-derived hormone (1)
whose plasma concentrations are proportional to fat
mass (2, 3) but are lowered rapidly by fasting in both
rodents and humans (4–6). Indeed, there is increasing
evidence that leptin is a key signal of nutritional status
regulating several aspects of metabolism and neuroen-
docrine function as part of an adaptive response to
starvation (4, 7).
Lymphoid atrophy is a well-recognized consequence of
nutritional deprivation in animals, including humans
(8–14). This disproportionate loss of lymphoid tissue
with starvation is particularly pronounced in the thy-
mus, which has been designated “the barometer of mal-
nutrition” (9). The thymus is crucial to T-cell develop-
ment; it provides the specialized microenvironment
required for T-cell maturation and the generation of a
diverse T-cell receptor repertoire (15–22). We have
demonstrated previously that the long isoform of the
leptin receptor, thought to be of prime importance in
leptin signaling, is expressed by mature CD4+ T cells and
that leptin is able to modulate the activity of these cells
directly (23). To our knowledge, the role of leptin in the
pathogenesis of starvation-induced thymic atrophy has
not been investigated previously.
Acute starvation causes a significant reduction in cir-
culating leptin levels (4–6). We therefore hypothesized
that exogenous administration of leptin during fasting
would protect mice from the lymphoid atrophy associ-
ated with acute starvation. We determined the effect of
leptin on the weight and cellularity of lymphoid and
nonlymphoid tissues in mice fasted for 48 hours and
compared this with the effects observed in PBS-treated
starved mice and ad libitum–fed controls. We also
looked at the effect of acute starvation with and without
leptin repletion on specific thymocyte and splenocyte
subpopulations and thymic histology.
Ob/ob mice are unable to produce functional leptin
because of a mutation in the obese gene (1). In addition
to a phenotype of insulin resistance and obesity, these
totally leptin-deficient mice display a number of features
seen in starvation including hyperphagia, infertility,
decreased body temperature, diminished energy expen-
diture, hypercorticosteronemia, and suppression of the
gonadal and thyroid axes (24–26). This has led to the
suggestion that these mice are in a state of perceived
chronic starvation because of their lack of leptin (4, 7).
Indeed, ob/ob mice have been found to exhibit defective
cell-mediated immunity and lymphoid atrophy (27, 28)
analogous to that observed in chronic human undernu-
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Thymic atrophy is a prominent feature of malnutrition. Forty-eight hours’ starvation of normal mice
reduced the total thymocyte count to 13% of that observed in freely fed controls, predominantly because
of a diminution in the cortical CD4+CD8+ thymocyte subpopulation. Prevention of the fasting-induced
fall in the level of the adipocyte-derived hormone leptin by administering exogenous recombinant lep-
tin protected mice from these starvation-induced thymic changes. The ob/ob mouse, which is unable to
produce functional leptin because of a mutation in the obese gene, has impaired cellular immunity
together with a marked reduction in the size and cellularity of the thymus. We found that ob/ob mice
had a high level of thymocyte apoptosis resulting in a ratio of CD4+CD8+ (cortical) to CD4–CD8– (pre-
cursor) thymocytes that was 4-fold lower than that observed in wild-type mice. Peripheral administra-
tion of recombinant leptin to ob/ob mice reduced thymocyte apoptosis and substantially increased both
thymic cellularity and the CD4+CD8+/CD4–CD8– ratio. In contrast, a comparable weight loss in pair-fed
PBS-treated ob/ob mice had no impact on thymocyte number. In vitro, leptin protected thymocytes from
dexamethasone-induced apoptosis. These data indicate that reduced circulating leptin concentrations
are pivotal in the pathogenesis of starvation-induced lymphoid atrophy.
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trition (10, 12–14, 29). Therefore, in order to examine the
effect of in vivo leptin replacement on lymphoid tissue
and thymocyte survival in a chronically leptin-deficient
model, we administered leptin to ob/ob mice. Finally, to
address whether leptin was able to influence the survival
of thymocytes directly, we determined the effect of lep-
tin on steroid-induced thymocyte apoptosis in vitro.
Methods
Mice. Ten-week-old male C57BL/6 wild-type and ob/ob
mice (Harlan UK, Oxford, United Kingdom) were
housed in pairs at 22–23ºC, with a 12-hour dark/12-
hour light cycle (lights on at 0700 hours).
Starvation experiment. Mice comprised 3 groups (n = 8
per group). One group was allowed ad libitum access to
laboratory chow and received intraperitoneal injections
of 0.2 mL PBS at 0900 and 1800 hours twice daily for 2
days. Two groups of mice were deprived of chow for 48
hours and received intraperitoneal injections of either
0.2 mL PBS or recombinant murine leptin (1 m g/g initial
body weight) at 0900 and 1800 hours. All mice were
allowed continuous access to water. This experimental
paradigm of leptin administration during starvation has
been shown to achieve circulating leptin concentrations
6 and 12 hours after injection, similar to that of ad libi-
tum–fed control mice and has been considered as
replacement therapy (4, 7, 23). At the end of 48 hours,
mice were sacrificed by CO2 inhalation and blood was
collected by terminal cardiac puncture between 0900 and
1000 hours and immediately centrifuged; the plasma
was separated and stored at –20°C until assayed for glu-
cose, insulin, and corticosterone.
Ob/ob mice. Mice comprised 3 groups (n = 6 per group).
One group was allowed to feed ad libitum, the second
group was injected with recombinant murine leptin (1
m g/g initial body weight twice daily intraperitoneally),
and the third group was pair-fed to the food intake of
the leptin-treated mice and received twice-daily injec-
tions of PBS. All mice were weighed, and their food
intake was recorded daily. On the morning after 10 days
of leptin administration, mice were sacrificed and blood
was collected as above. All the experiments were per-
formed according to British Home Office regulations.
Assays. Glucose was measured by the glucose oxidase
method (YSI 2300 Stat Plus glucose analyzer; Yellow
Springs Instrument Co. Yellow Springs, Ohio, USA).
Plasma insulin was measured by RIA as described previ-
ously (30). Plasma corticosterone concentration was
measured using a commercially available RIA (ICN Bio-
medicals Inc. Costa Mesa, California, USA).
Organ weight/cellularity. Organs were removed from sac-
rificed mice, and liver and kidney weights were deter-
mined to the nearest 0.01 g. Spleens were removed and
weighed to the nearest 0.1 mg. A single-cell suspension
of splenocytes was prepared using the blunt end of a
syringe and passing the suspension through nylon
gauze. Red blood cells were lysed with ammonium chlo-
ride lysing buffer. All thymic tissue was carefully
removed using fine forceps after exposure of the chest
cavity and weighed to the nearest 0.1 mg. Thymic weight
was not determined in the ob/ob mice because it was not
possible to completely dissect this organ free of its sur-
rounding connective tissue. A single-cell suspension of
thymocytes was prepared by teasing the thymuses with
sterile needles on a Petri dish. Red cells were lysed with
ammonium chloride lysing buffer. Splenocyte and thy-
mocyte numbers were determined by counting cells 3
times from different areas of a hemocytometer and cal-
culating the mean cell counts. Cell subpopulations were
analyzed by 2-color flow cytometry using a FACScalibur
(Becton Dickinson Immunocytometry Systems, Moun-
tain View, California, USA) with the appropriate FITC-
or phycoerythrin-conjugated mAb’s (anti-CD4, anti-
CD8; PharMingen, San Diego, California, USA).
Histology. The acute starvation experiment was repeat-
ed using the protocol above in age-matched mice. On
this occasion intact thymuses were removed, formalin-
fixed, paraffin-embedded, sectioned, and stained with
hematoxylin and eosin (H&E) for histologic evaluation
of thymic architecture.
Apoptosis experiments. Thymocyte apoptosis was deter-
mined by flow-cytometric analysis of annexin-V binding
to thymocytes counterstained with propidium iodide
(PI). Annexin V is a calcium-dependent phospholipid-
binding protein with a high affinity for phospha-
tidylserine. This molecule is normally present in the
inner lipid bilayer, but becomes exposed on the
cell surface within the first few hours of the onset
of apoptosis (31). PI is a red DNA-binding dye
that can only enter cells whose membranes are
disrupted. The effect of in vivo leptin adminis-
tration on thymocyte survival was determined by
comparing the level of apoptosis in thymocytes
freshly harvested from ob/ob mice chronically
treated with leptin (as described above) with that
of freshly harvested thymocytes from pair-fed
and ad libitum–fed ob/ob and wild-type mice (n =
6 per group). To investigate whether leptin had a
direct anti-apoptotic action on thymocytes, we
determined the effect of leptin on dexametha-
sone-induced apoptosis of thymocytes in vitro.
Water-soluble dexamethasone (Sigma Chemical
Co., St. Louis, Missouri, USA) was used at a final
concentration of 10–7 M. Freshly harvested thy-
mocytes from wild-type mice were washed once
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Table 1
Effect of leptin administration during acute starvation in C57BL/6 mice
Ad libitum–fed Starve/PBS Starve/leptin
Initial body weight (g) 21.6 ± 0.4D 21.7 ± 0.5A 21.4 ± 0.5A,D
Final body weight (g) 21.6 ± 0.4F 17.5 ± 0.4C 17.0 ± 0.3C,D
Liver weight (g) 1.24 ± 0.05F 0.77 ± 0.05C 0.77 ± 0.02C,D
Liver/100 g body weight 5.71 ± 0.14F 4.37 ± 0.22C 4.51 ± 0.07C,D
Kidney weight (g) 0.26 ± 0.01E 0.23 ± 0.01B 0.22 ± 0.01C,D
Kidney/100 g body weight 1.12 ± 1.58D 1.32 ± 0.04A 1.27 ± 0.03A,D
Spleen weight (mg) 64.5 ± 4.0F 38.0 ± 3.4C 48.2 ± 2.7B,D
Spleen/100 g body weight 0.30 ± 0.02E 0.22 ± 0.02B 0.29 ± 0.02A,E
Splenocyte count ( · 106) 33.0 ± 2.88F 13.8 ± 2.11C 26.1 ± 3.26A,E
Thymus weight (mg) 42.5 ± 3.2F 14.1 ± 2.1C 35.1 ± 3.6A,F
Thymus/100 g body weight 0.20 ± 0.01F 0.08 ± 0.01C 0.21 ± 0.02A,F
Thymocyte count ( · 106) 76.3 ± 5.57F 10.0 ± 1.56C 68.0 ± 8.21A,F
Glucose (mmol/L) 14.5 ± 1.53F 6.33 ± 0.71C 5.14 ± 0.71C,D
Insulin (pmol/L) 99.0 ± 12.4E 30.1 ± 12.5B 41.5 ± 16.6B,D
Corticosterone (ng/mL) 85.6 ± 13.5E 221 ± 53.5B 178.2 ± 33.5B,D
Values represent mean ± SEM. AP = NS, BP < 0.05, CP < 0.001 vs. ad libitum–fed controls. DP
= NS, EP < 0.05, FP < 0.001 vs. PBS-treated starved controls. NS, not significant.
with culture medium (RPMI, 10% FCS) and incubated
overnight at 37°C at a concentration of 10 · 106 thymo-
cytes in 1 mL of medium in 1 of 3 conditions: (a) medi-
um alone (b) dexamethasone alone (c) leptin (10–8 M)
and dexamethasone. Thymocytes were also cultured at
4ºC as a negative control. Cells were then washed and
immediately stained with annexin V–FITC (Roche Diag-
nostics Ltd., East Sussex, United Kingdom) in the appro-
priate buffers and counterstained with PI as described
previously (32). The levels of FL1-H (stained with annex-
in V–FITC) and FL2-H (stained with PI) were analyzed
on a FACScalibur flow cytometer (Becton Dickinson
Immunocytometry Systems).
Statistical analyses. Analyses were performed using 1-way
ANOVA with Tukey post hoc testing for normally dis-
tributed data or by Kruskal-Wallis ANOVA for skewed
data. Results are expressed as mean ± SEM; P values less
than 0.05 were considered to be statistically significant.
Results
Acute starvation led to a disproportionate fall in lymphoid mass.
The effect of acute starvation with and without exoge-
nous leptin administration on the body weight, organ
weight, and metabolic parameters of wild-type C57BL/6
mice are shown in Table 1. The greatest effect of acute
starvation was on the thymus (Figure 1). Mice treated
with leptin during the period of starvation were com-
pletely protected against the profound thymic atrophy
induced by the 48-hour fast (Figure 1a). Although not as
dramatic as the changes observed in the thymus, starva-
tion for 48 hours also caused a significant reduction in
splenic weight. The effect of starvation on splenic atro-
phy was significantly blunted when exogenous leptin was
administered during the period of starvation (Figure 1b).
In contrast to the effect of leptin on lymphoid tissue, lep-
tin administration during fasting had no impact on non-
lymphoid tissue mass (Table 1; Figure 1, c and d).
The effects of acute starvation on thymocyte subpopulations
were reversed by leptin. Acute starvation caused a dramat-
ic fall in the mean total thymocyte count to 13% of that
observed in control mice (Table 1). This reduction in
total thymic cellularity was mirrored by a reduction in
the absolute numbers of all thymocyte subsets examined
(Figure 1e). The greatest effect of fasting was seen in the
double-positive CD4+CD8+ thymocyte subpopulation.
Starvation caused a reduction in both the absolute cell
number (Figure 1e) and the overall relative proportion
of CD4+CD8+ thymocytes (66.0 ± 1.26%) compared with
that observed in ad libitum–fed mice (76.2 ± 1.32%; P <
0.001). Although acute starvation caused a relative
increase in the overall percentage of single-positive
CD4+CD8– thymocytes (17.0 ± 0.7% [fasted, PBS] vs. 11.1
± 0.69% [fed]; P < 0.005), there was still a significant
reduction in absolute numbers of CD4+ CD8– thymo-
cytes in the PBS-treated starved group compared with
the ad libitum–fed controls (1.90 ± 0.24 [fasted, PBS] vs.
8.36 ± 0.61 million [fed]; P < 0.0001). Leptin protected
completely against these starvation-induced changes in
both thymocyte number (Figure 1e) and subpopulation
proportions (percent CD4+CD8+ thymocytes: 76.6 ± 1.92
[fasted, leptin] vs. 76.2 ± 1.32 [fed], P = NS; percent
CD4+CD8– thymocytes: 10.8 ± 1.39 [fasted, leptin] vs.
11.1 ± 0.69 [fed], P = NS). The relative proportions of
CD4–CD8– or CD4–CD8+ thymocytes were not signifi-
cantly affected by starvation or leptin treatment.
Leptin spared splenic T cells from the effects of acute starvation.
Forty-eight–hour starvation resulted in a 42% reduction in
the total number of splenocytes (Table 1; Figure 1f). The
absolute number of splenocytes negative for both CD4 and
CD8 (non–T cells) was particularly reduced by acute star-
vation (7.53 ± 1.31 [fast, PBS] vs. 21.5 ± 2.46 million [fed]),
although leptin was able to only partially prevent the fast-
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Figure 1
The effect of leptin administration during starvation on lymphoid (a, b,
e, and f) and nonlymphoid tissues (c and d) in C57BL/6 mice. (a) Thymic
weight, (b) splenic weight, (c) liver weight, (d) kidney weight, (e) thymo-
cyte subpopulations, and (f) splenic subpopulations. Values represent
mean ± SEM. *P < 0.05 vs. ad libitum–fed controls; **P < 0.05, ***P <
0.0001 PBS-treated starved mice vs. both ad libitum–fed controls and
leptin-treated starved mice. 
ing-induced changes in this subpopulation (15.1 ± 2.36 mil-
lion [fast, leptin]). The greatest effect of leptin was seen in
the CD4+ splenic T-cell subpopulation. Starvation reduced
the number of CD4+ splenocytes to 56% that of fed controls
(3.92 ± 0.53 [fast, PBS] vs. 6.98 ± 0.69 million [fed]), an effect
that was completely abrogated by the administration of
exogenous leptin (7.35 ± 0.76 million [fast, leptin]). A simi-
lar trend was seen in the CD8+ subset (Figure 1f).
Leptin protected against the starvation-induced loss of cortical
thymocytes. Representative histologic sections of thy-
muses from each group are shown in Figure 2. The nor-
mal corticomedullary differentiation of the thymus (Fig-
ure 2, a and b) was lost following starvation, reflecting a
marked reduction in the number of cortical thymocytes
with relative preservation of the medullary architecture
(Figure 2c). In contrast, the thymuses from starved mice
treated with exogenous leptin during starvation retained
corticomedullary differentiation and cortical thymocyte
density (Figure 2, e and f). In the PBS-treated starved thy-
muses, there were abundant small, darkly stained apop-
totic thymocytes visible throughout the remaining cor-
tex (Figure 2d). Although occasional apoptotic thymo-
cytes were seen in leptin-treated starved thymuses, they
were far less prevalent than in thymuses from the PBS-
treated starvation group.
The starvation-induced changes in plasma insulin, glucose, and
corticosterone were not significantly affected by leptin. Starva-
tion of both PBS and leptin-treated mice caused a simi-
lar significant reduction in both plasma glucose and
insulin concentrations (Table 1). As expected, fasting was
associated with a significant increase in plasma corti-
costerone concentrations. However, although leptin
treatment during fasting somewhat blunted the starva-
tion-induced rise in plasma corticosterone, this effect
was not statistically significant (Table 1).
The thymus of the obese (ob/ob) C57BL/6 mouse is markedly
hypocellular. Details of the organ weight and cellularity in
10-week-old C57BL/6 ob/ob mice and age-matched wild-
type controls are shown in Table 2. As anticipated, body
and liver weights were significantly greater in the ob/ob
mice in comparison with the wild-type mice. Splenic
weights were significantly lower in the ob/ob mice com-
pared with the wild-type controls, although total spleno-
cyte number was similar. Indeed, there was no significant
difference in the relative proportion of the different
splenocyte subpopulations examined between ob/ob and
wild-type mice. In contrast, thymic cellularity was dra-
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Table 2
Characteristics of 10-week-old lean (+/+) and obese (ob/ob) mice
Lean (+/+) Obese (ob/ob)
Body weight (g) 21.6 ± 0.4 43.4 ± 0.9D
Liver weight (g) 1.24 ± 0.05 3.18± 0.17D
Liver/100 g body weight 5.71 ± 0.14 7.39 ± 0.37C
Spleen weight (mg) 64.5 ± 4.0 37.4 ± 2.70D
Spleen/100 mg body weight 0.30 ± 0.02 0.09 ± 0.01D
Total splenocyte count ( · 106) 33.0 ± 2.88 26.7 ± 3.00A
CD4–CD8– splenocytes (% total) 66.6 ± 1.13 66.7 ± 2.32A
CD4+ splenocytes (% total) 21.7 ± 0.40 22.1 ± 2.21A
CD8+ splenocytes (% total) 10.7 ± 0.77 11.1 ± 0.70A
Total thymocyte count ( · 106) 76.3 ± 5 .57 0.42 ± 0.17D
CD4+CD8+ thymocytes (% total) 76.2 ± 1.32 49.3 ± 7.23B
CD4–CD8– thymocytes (% total) 5.41 ± 0.93 21.2 ± 7.31B
CD4+CD8– thymocytes (% total) 11.1 ± 0.69 23.0 ± 0.76B
CD4–CD8+ thymocytes (% total) 5.16 ± 1.49 6.51 ± 0.71A
Ratio CD4+CD8+/CD4–CD8– 16.7 ± 3.21 3.39 ± 1.67B
Values represent mean ± SEM. AP = NS. BP < 0.05. CP < 0.005. DP < 0.001.
Figure 2
The effect of leptin administration during starvation
on thymic histology in C57BL/6 mice. (a and b) Ad
libitum–fed controls. (c and d) PBS-treated starved
mice. (e and f) Leptin-treated starved mice. Sections
are stained with H&E and shown at · 25 (a, c, and e)
and · 250 (b, d, and f). c, cortex; m, medulla; a,
apoptotic thymocytes.
matically reduced in the ob/ob mice in comparison with
wild-type mice with a significant alteration in the relative
proportions of the examined thymocyte subpopulations
between the two groups. Ob/ob mice had a significantly
lower percentage of CD4+CD8+ thymocytes and a signif-
icantly higher percentage of CD4–CD8– and CD4+CD8–
thymocytes compared with wild-type mice. Indeed, there
was a greater than 4-fold reduction in the ratio of
CD4+CD8+ to CD4–CD8– thymocytes in the ob/ob mice
compared with wild-type mice (Table 2).
Leptin administration increased thymic cellularity in ob/ob mice.
The effects of administering recombinant leptin for 10
days on organ weight, cellularity, and metabolic parame-
ters in ob/ob mice are shown in Table 3. Leptin administra-
tion led to a similar reduction in body weight and liver
mass in both food-restricted and leptin-treated mice (Fig-
ure 3, a and b). Although splenic weight was significantly
higher in leptin-treated mice than both ad libitum and
food-restricted controls, there was no statistical difference
when total splenocyte numbers or splenocyte subpopula-
tions were compared between groups (Figure 3c). Leptin
treatment of ob/ob mice had a considerable impact on the
thymus. Whereas food restriction alone had no significant
effect on total thymocyte count, leptin treatment in ob/ob
mice caused an 18-fold increase in total thymic cellularity
(Figure 3d). This leptin-induced increase in thymocyte
number was seen in all examined thymocyte subpopula-
tions. The greatest increment, however, was found in the
number of CD4+CD8+ thymocytes, with a relative reduc-
tion in the number of CD4–CD8– thymocytes. Indeed,
there was a 3-fold increase in the proportion of CD4+CD8+
to CD4–CD8– thymocytes following chronic leptin admin-
istration (10.2 ± 1.78), whereas this ratio remained similar
in the pair-fed and ad libitum–fed mice (3.93 ± 1.57 and
3.39 ± 1.67, respectively; P = NS). Representative flow-cyto-
metric analyses with CD4 and CD8 staining of thymocytes
from wild-type mice and ob/ob mice are shown in Figure 4.
The metabolic effects of leptin administered peripher-
ally for 10 days to ob/ob mice are shown in Table 3. There
was a similar reduction in plasma glucose concentration
in the food-restricted mice and the leptin-treated mice.
Leptin treatment reduced plasma insulin levels of ob/ob
mice to a greater extent than that observed by a similar
degree of food restriction and weight loss; however, this
effect did not reach statistical significance. After 10 days
of exogenous leptin administration, the mean plasma
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Figure 3
The effect of chronic leptin administration on (a) body weight, (b) liver weight, (c) splenocyte subpopulations, and (d) thymocyte subpopulations
in ob/ob mice. Values represent mean ± SEM. *P < 0.05 vs. ad libitum–fed controls. **P < 0.05, ***P < 0.0005, PBS-treated starved mice vs. both ad
libitum–fed and pair-fed control mice.
corticosterone concentration was not statistically differ-
ent between any of the groups of ob/ob mice (Table 3).
Thymocyte apoptosis was reduced by in vivo treatment of
ob/ob mice with leptin. Representative flow-cytometric
analyses with annexin V and PI staining of thymocytes
are shown in Figure 5. Thymocytes derived from wild-
type mice had a low level of apoptosis (Figure 5a) com-
pared with those from ad libitum–fed ob/ob mice (Figure
5b). Analysis of thymocyte apoptosis from pair-fed ob/ob
mice gave results similar to ad libitum–fed ob/ob mice
(not shown). Leptin treatment in vivo reduced the level
of apoptosis in thymocytes from ob/ob mice to that
observed in wild-type control mice (Figure 5c).
Leptin protected thymocytes from steroid-induced apoptosis in
vitro. Murine thymocytes cultured at 37°C underwent
spontaneous apoptosis (Figure 6a), the level of which
was increased in the presence of dexamethasone (Figure
6b). Dexamethasone-induced thymocyte apoptosis was
completely prevented by the presence of leptin in the cul-
tures (Figure 6c).
Discussion
Lymphoid atrophy has long been recognized
as a prominent feature of starvation in ani-
mals and humans (8–14); our findings now
suggest that the reduction in plasma leptin
concentration with fasting is of prime
importance in its pathogenesis. Consistent
with previous reports (8, 9–12), the thymus
underwent the most profound reduction in
weight and cellularity with starvation.
Whereas the mass of nonlymphoid organs
(kidney and liver) were unaffected by leptin
treatment during fasting, we have shown
that exogenous leptin, administered only
during the period of fasting, was able to
completely protect against the thymic atro-
phy induced by acute starvation. Similar results were
observed for the spleen, although the effects of both
fasting and the response to exogenous leptin were less
dramatic in this organ.
Thymocyte subpopulations at different stages of matu-
ration are found in distinct parts of the thymus and can
be distinguished by their expression of cell-surface mole-
cules, the most important of which are the CD4, CD8, and
T-cell receptor molecules. The greatest loss in thymocyte
number with acute starvation was in the double-positive
(CD4+CD8+) thymocyte subpopulation. Leptin treatment
during starvation completely protected against the fast-
ing-induced loss of these immature thymocytes. As the
double-positive thymocyte is the major cell type in the
thymic cortex, this finding is consistent with the dramat-
ic reduction in cortical cellularity and loss of corti-
comedullary differentiation observed histologically fol-
lowing starvation. In addition, many of the remaining
cortical thymocytes in the PBS-treated starved thymuses
appeared apoptotic. In contrast, in the thymuses taken
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Table 3
Effect of chronic leptin administration in ob/ob mice
Ad libitum–fed Food-restricted Leptin-treated
Initial body weight (g) 43.4 ± 0.9D 44.1 ± 1.3A 43.6 ± 0.9A,D
Final body weight (g) 43.0 ± 0.9E 38.4 ± 1.0B 36.8 ± 1.1B,D
Liver weight (g) 3.18 ± 0.17E 2.12 ± 0.29B 1.93 ± 0.16B,D
Liver/100 g body weight 7.39 ± 0.37E 5.45 ± 0.67B 5.22 ± 0.20B,D
Spleen weight (mg) 37.4 ± 2.70D 34.0 ± 3.7A 56.7 ± 5.90B,E
Spleen/100 g body weight 0.09 ± 0.01 D 0.09 ± 0.01 A 0.16 ± 0.02B,E
Splenocyte count ( · 106) 26.7 ± 3.00D 31.7 ± 5.90A 39.6 ± 3.20A,D
Thymocyte count ( · 106) 0.42 ± 0.17D 1.01 ± 0.05A 7.88 ± 0.94C,F
Glucose (mmol/L) 36.4 ± 2.60F 14.8 ± 1.06C 17.1 ± 1.40C, D
Insulin (pmol/L) 3701 ± 347F 1559 ± 201C 712 ± 169C,D
Corticosterone (ng/mL) 213.1 ± 48.3D 197.4 ± 40.6A 123.0 ± 53.8A,D
Values represent mean ± SEM. AP = NS, BP < 0.05, CP < 0.001 vs. ad libitum–fed controls. DP = NS,
EP < 0.05, FP < 0.001 vs. food-restricted controls.
Figure 4
Representative flow-cytometric analyses of thymo-
cytes stained for CD4 and CD8. (a) Wild-type mice,
(b) ad libitum–fed ob/ob mice, (c) pair-fed ob/ob
mice, and (d) leptin-treated ob/ob mice.
from mice that had been treated with leptin during star-
vation, the cortex was well preserved and apoptotic thy-
mocytes were sparse. The more mature single-positive thy-
mocytes reside in the thymic medulla. The observed
increase in the overall proportion of single-positive
CD4+CD8– thymocytes remaining in the PBS-treated
starved thymuses is, therefore, likely to reflect the relative
preservation of the thymic medulla over the cortex during
starvation. However, because a small proportion of the
earliest T-lineage precursors is also CD4+CD8– in mice
(33), it is feasible that an interruption of early thymocyte
maturation could contribute to the observed increase in
the relative proportion of this subset. The absolute num-
ber of single-positive CD4+CD8– thymocytes was, never-
theless, still significantly reduced by starvation. Again,
these fasting-induced changes in thymocyte subpopula-
tion number and proportion were not seen if exogenous
leptin was administered during the period of starvation.
Leptin was partially able to protect against the effect of
acute starvation in reducing the total number of spleno-
cytes in wild-type mice. However, it was only in the CD4+
splenic T-cell subpopulation that leptin was found to
completely abrogate the effect of acute starvation.
Splenocytes negative for both CD4 and CD8 comprise a
heterogeneous population of cell types including B cells,
natural killer (NK) cells, and macrophages. Collectively,
leptin treatment was able to only partially protect these
cells against the effects of acute starvation. These find-
ings would suggest that factors in addition to the fast-
ing-induced fall in leptin are responsible for the overall
reduction in this splenocyte subpopulation with starva-
tion. Whether leptin has differential effects on the sur-
vival of the individual cell types that comprise this sub-
population remains to be determined.
Like others, we found that the spleens of ob/ob mice were
significantly smaller compared with those of age-matched
wild-type mice (27, 28). Although the absolute splenocyte
number and relative proportions of the various splenocyte
subpopulations expressing CD4 and CD8 markers tend-
ed to be lower in the ob/ob mice than wild-type mice, these
differences were not statistically significant. It is therefore
not surprising that although treatment of ob/ob mice for
10 days with recombinant leptin significantly increased
spleen size, it was without a significant impact on total
splenocyte number or subpopulation proportions. In
chronic leptin deficiency, unlike acute starvation (where
circulating leptin concentrations are rapidly lowered), the
number of splenocytes expressing CD4 or CD8 markers
appears to be relatively well maintained.
In marked contrast to our findings in the spleen, the
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Figure 5
Representative flow-cytometric analyses of thymocytes stained with annexin V and PI. (a) Wild-type mice. (b) Ad libitum–fed ob/ob mice. (c) Leptin-
treated ob/ob mice. Shown are live thymocytes (lower-left quadrant), thymocytes in the early stages of apoptosis (lower-right quadrant), thymocytes
in the late stages of apoptosis (upper-right quadrant), and dead thymocytes (upper-left quadrant).
Figure 6
Representative flow-cytometric analyses of wild-type C57BL/6 thymocytes stained with annexin V and PI, and cultured in vitro with (a) medium alone
(b) dexamethasone alone, and (c) dexamethasone and leptin. Shown are live thymocytes (lower-left quadrant), thymocytes in the early stages of
apoptosis (lower-right quadrant), thymocytes in the late stages of apoptosis (upper-right quadrant), and dead thymocytes (upper-left quadrant).
cellularity of the thymus was considerably lower in ob/ob
compared with wild-type mice. In addition, the ob/ob
mice had a significantly lower percentage of double-pos-
itive and higher percentage of double-negative and
CD4+CD8– thymocytes compared with age-matched
wild-type controls. In wild-type mice, where food restric-
tion reduced thymocyte number, food restriction in
ob/ob mice had no further suppressive effect on the
already reduced thymic cellularity. As was the case when
exogenous leptin was administered to fasted wild-type
mice, leptin administration to ob/ob mice had a dra-
matic effect on thymic cellularity. After only 10 days,
thymocyte number had increased by over 18-fold in the
leptin-treated ob/ob mice. This augmentation of thy-
mocyte number was seen in all thymocyte subpopula-
tions. However, as we observed with leptin treatment
during acute starvation, this overall improvement was
largely due to an increase in the double-positive thymo-
cyte number. The abnormally low ratio of double-posi-
tive to double-negative thymocytes we had observed in
ob/ob compared with wild-type mice was also improved
by chronic leptin administration. The double-positive
thymocytes are by far the most numerous cells in the
normal thymus, and any reduction in their number
would certainly be expected to have a major impact on
total thymic cellularity. It therefore seems likely that the
effect of leptin in protecting against thymic atrophy
may be due to its influence on the survival of, or entry
into, this immature thymocyte subpopulation.
Starvation is accompanied by significant metabolic and
endocrine changes that could potentially contribute to
the observed lymphoid atrophy. However, the starvation-
induced fall in plasma insulin and glucose concentrations
was not significantly affected by leptin administered dur-
ing 48 hours of starvation in wild-type mice, consistent
with a previous report (4). As anticipated, leptin treatment
of ob/ob mice was found to reduce food intake and body
weight (34–38). The resulting improvement in insulin sen-
sitivity was reflected by reduced plasma insulin and glu-
cose concentrations (36–38). Similar reductions in these
parameters were observed in both the leptin-treated and
the food-restricted ob/ob mice. It therefore seems unlike-
ly, at least in these models, that leptin’s effect on thymic
cellularity is secondary to changes in insulin or glucose.
Activation of the hypothalamic-pituitary-adrenal (HPA)
axis is a feature of nutritional deprivation (4, 25). Admin-
istration of recombinant leptin during fasting has been
shown to blunt (although not prevent) the starvation-
induced rise in plasma corticosterone in mice fasted for 48
hours (4). Another study reported that leptin had no sig-
nificant impact on the increase in corticosterone observed
after 24 hours of fasting in lean mice (39). In our experi-
ments we have also found that, although leptin tended to
decrease the fasting-induced rise in corticosterone con-
centrations, the levels remained statistically similar to that
of PBS-treated starved control mice. This regime of leptin
administration during acute starvation, however, was able
to completely reverse the effects of starvation on thymic
involution. Furthermore, there was a marked increase in
thymic cellularity after just 10 days of leptin administra-
tion to ob/ob mice, over which time period plasma corti-
costerone concentrations were not significantly reduced
by leptin treatment. The effects of glucocorticoids on the
thymus are complex; intrathymic production of gluco-
corticoids is well established, and their importance in anti-
gen-specific thymocyte development and survival is
becoming increasingly recognized (40–44). However,
because glucocorticoids are also well-known to have lym-
pholytic effects (45–47), with an effect on the immature
cortical thymocyte subpopulation in particular (47), it is
still possible that suppression of the HPA axis may make
some contribution to the observed lymphoprotective
effect of leptin in vivo. As leptin administration has also
been shown to blunt the suppressive effects of fasting on
the thyroid, gonadal, and growth hormone axes (4, 48), a
potential contribution of other leptin-induced endocrine
changes to the overall lymphoprotective action of leptin
cannot be excluded. It remains to be seen whether an
intracerebroventricular infusion of leptin, administered
at a centrally effective dose that had no effect on periph-
eral circulating leptin levels, would be able confer similar
protection against starvation-induced thymic atrophy as
was seen with peripheral leptin administration in this
study. We have, however, demonstrated that an enhanced
level of thymocyte apoptosis underlies the marked thymic
atrophy found in the leptin-deficient ob/ob mouse and
that leptin administration in vivo is able to inhibit this
process. Furthermore, we have shown that leptin can
inhibit the steroid-induced apoptotic pathway in thymo-
cytes cultured in vitro. Leptin has been found previously
to inhibit induced apoptosis in pancreatic beta cells (49).
It now seems likely that the ability of leptin to protect
against thymic atrophy also involves a direct anti-apop-
totic mechanism.
Since its first description in 1810, starvation has been
recognized to cause a disproportionate depletion of lym-
phoid tissue compared with nonlymphoid tissue. These
changes affect the thymus in particular (8–14). We have
found that prevention of the starvation-induced reduc-
tion in plasma leptin concentration by exogenous
administration of recombinant leptin was able to protect
normal mice from this “nutritional thymectomy.” In
addition, leptin administered chronically to ob/ob mice
dramatically improved their marked thymic hypocellu-
larity. Because the majority of thymocytes (over 95%) die
within the thymus as a result of mechanisms designed to
delete autoreactive, non–self restricted cells (15–22), the
thymus is an energy-expensive organ (50). Our findings
are consistent with the hypothesis that the physiological
role of leptin is as a signal of starvation (4, 7, 23). We pro-
pose that a reduced leptin concentration is pivotal to the
pathogenesis of starvation-induced lymphoid atrophy.
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